People who have airway spasms caused by chronic obstructive pulmonary disease may receive Tudorza. This prescription medication is inhaled into the lungs twice daily. Headaches, coughing, and common cold symptoms are possible side effects. As an anticholinergic, this product works by relaxing the muscles of the airways, helping to keep them open.
Tudorza belongs to a group of medications known as anticholinergics. By binding to specific receptors (called muscarinic receptors) in the airway, Tudorza helps to relax the smooth muscle of the airway. As a long-acting medication, it helps to prevent bronchospasms, helping to keep the airways open, with just two doses each day.
Tudorza was studied in the treatment of COPD. People using this medication showed improved lung function, compared to those not using it. In addition, these studies showed that the effects of each dose lasted for at least 12 hours, and people who used the medication were less likely to need doses of "rescue" inhalers, such as albuterol.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 20, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click